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Auditory hallucinations (AH) are often considered a sign of a psychotic disorder. This is promoted by the DSM-5 cat-
egory of Other Speciﬁed Schizophrenia Spectrum And Other Psychotic Disorder (OSSSOPD), the diagnostic criteria
for which are fulﬁlled with the sole presence of persistent AH, in the absence of any other psychotic symptoms. And
yet, persistent AH are not synonymous with having a psychotic disorder, and should therefore not be uncritically treated
as such. Many people who seek treatment for persistent AH have no other psychotic symptoms, have preserved reality-
testing capacities, and will never develop a schizophrenia spectrum disorder. Instead, hallucinations may be the result of
many different causes, including borderline personality disorder, post-traumatic stress disorder (PTSD), hearing loss,
sleep disorders or brain lesions, and they may even occur outside the context of any demonstrable pathology. In such
cases, the usage of the DSM-5 diagnosis of OSSSOPD would be incorrect, and it may prompt unwarranted treatment
with antipsychotic medication. We therefore argue that a DSM-5 diagnosis of Schizophrenia Spectrum Disorder (or
any other type of psychotic disorder) characterized by AH should require at least one more symptom listed under
the A-criterion (i.e. delusions, disorganized speech, disorganized or catatonic behavior or negative symptoms).
Adhering to these more stringent criteria may help to distinguish between individuals with persistent AH which are
part of a psychotic disorder, for whom antipsychotic medication may be helpful, and individuals with AH in the
absence of such a disorder who may beneﬁt from other approaches (e.g. different pharmacological interventions, improv-
ing coping style, trauma-related therapy).
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Introduction
In the general community, and even among health pro-
fessionals, the presence of auditory hallucinations (AH)
is often considered synonymouswith having a psychotic
disorder (Parnas, 2013; Ford et al. 2014). This view is pro-
moted by the diagnostic criteria for Other Speciﬁed
Schizophrenia Spectrum and Other Psychotic Disorder
(OSSSOPD), a diagnostic category ﬁrst introduced in
the ﬁfth edition of the Diagnostic and Statistical Manual
of Mental Disorders (DSM-5) (American Psychiatry
Association, 2013). For related categories in the schizo-
phrenia spectrum, such as Schizophrenia,
Schizophreniform Disorder, and Schizoaffective
Disorder, at least two symptoms are required from
those listed under the A-criterion (comprising delusions,
hallucinations, disordered thinking, disorganized or
catatonic behavior, and negative symptoms). To meet
theDSM-5 criteria for a diagnosis ofOSSSOPD, however,
the sole presence of persistent AH is sufﬁcient. This is at
odds with the fact that AH are experienced frequently
in the context of other conditions, and sometimes even
in the absence of any demonstrable pathology. Given
that persistent AH are not always associated with a loss
of contact with reality, lack of insight, or compromised
dopaminergic transmission, it is questionable whether
these types of AH should be treated with antipsychotic
medication. Getting this issue right is also important
given the stigma associatedwith a diagnosis of psychotic
disorder and possible consequences for prognosis.
In this paper, we argue for a clearer distinction
between AH as part of a psychotic disorder and those
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experienced in a different context, as the former may be
an indication for antipsychotic drugs, while the latter
may beneﬁt from an alternative therapeutic approach.
In what follows, we (i) consider the representation of
hallucinations in the DSM-5 chapter on Schizophrenia
Spectrum Disorders; (ii) highlight the crucial difference
between psychotic disorders and psychotic symptoms;
(iii) document alternative disorders with AH as a prom-
inent feature which occur in relative isolation, i.e. in the
absence of any other psychotic symptoms; (iv) discuss
biological, environmental, and psychological explana-
tions for AH that do not involve dopamine; and (v) con-
siderwhetherAHare a risk factor for later psychosis. On
the basis of these insights, we advocate a more stringent
use of theDSM’sA-criterion, requiring the presence of at
least two symptoms in cases of OSSSOPD.Although the
focus here is on nonverbal and verbal AH (i.e. ‘voices’),
our argument also applies to hallucinations experienced
in other sensory modalities (i.e. visual, somatic, etc.).
Hallucinations as a symptom domain in the DSM-5
According to the DSM-5, Schizophrenia and
Schizophreniform Disorder are diagnosed in the pres-
ence of two or more symptoms listed under the
A-criterion, along with signs of persistence, distress,
and impairments in functioning. One of the changes
made after the DSM-IV was to drop the use of
Schneiderian ﬁrst-rank symptoms, including voices
conversing and third-person hallucinations (Esquirol,
1845). Consequently, it is now possible to establish a
diagnosis of Schizophrenia or Schizophreniform
Disorder whenever hallucinations are present, regard-
less of form or content, as long as they are accompan-
ied by a second symptom from the A-criterion,
together with signiﬁcant distress or impairment in
functioning (APA, 2013).
The category OSSSOPD was devised for clinical pre-
sentations that are deemed ‘characteristic’ of the group
of Schizophrenia Spectrum Disorders, but which do not
meet all the diagnostic criteria of Schizophrenia or
Schizophreniform Disorder. The diagnosis can be estab-
lished in the sole presence of persistent AH, i.e. in the
absence of any other features (Box 1). An important
beneﬁt of this low-threshold residual category is that it
helps to alert health professionals to the presence of AH
in need of treatment, even in the absence of additional
symptoms required for a diagnosis of Schizophrenia.
Thus, patients suffering exclusively from distressing
and burdensome hallucinations (for example command
hallucinations) can be treated without delay. However,
this creates a new problem of overinclusion, because
any individual presenting with AH may now become
labelled as having a psychotic disorder, even if the pri-
mary condition is a somatic disorder (e.g. migraine or
Parkinson’s disease), other psychiatric disorder (e.g. dis-
sociative disorder or personality disorder) or not demon-
strable at all. The risk is that patients might be given
unnecessary treatment and suffer from stigmatization.
Incidentally, the risk of overinclusion is not unique to
Schizophrenia Spectrum Disorders (Berrios, 1996), but
this issue has received little attention in the literature.
Psychotic disorder v. psychotic symptom
Psychosis is a broad and rather non-speciﬁc term
(David & Ajnakina, 2016). It has been in use since
the 1900s, when physicians began attributing mental
disorders (or ‘insanities’) to underlying disorders of
the brain. Since then, the term is featured in virtually
every textbook of psychiatry, but is seldom explicitly
deﬁned. Even Sims (Sims, 2003), whose crystal-clear
deﬁnitions of psychopathology have instructed genera-
tions of psychiatrists, has little more to say than that
psychoses are ‘exceedingly hard to deﬁne although they
are usually said to be characterized by severe symptoms,
such as delusions and hallucinations, and by lack of insight
(. . .); there is loss of contact with reality.’ In clinical prac-
tice, the term psychosis loosely encompasses a spec-
trum of diagnostic syndromes which includes
schizophrenia and related disorders, the affective
Box 1. DSM-5 criteria for Other Speciﬁed Schizophrenia
Spectrum and Other Psychotic Disorder (OSSSOPD)
This category applies to presentations where are prominent
symptoms characteristic of schizophrenia spectrum disorders
that cause clinically signiﬁcant distress or impairment in
social, occupational, or other important areas of functioning
but do not meet the full criteria for schizophrenia, schizophre-
niform disorder or schizoaffective disorder. The OSSSOPD
category is used in situations in which the clinician chooses
to communicate that the presentation does not meet the cri-
teria for a more speciﬁc schizophrenia spectrum disorder,
and allows him or her to provide a speciﬁc reason for this
(e.g. ‘persistent auditory hallucinations’).
Examples of presentations that can be speciﬁed using the
‘other speciﬁed’ designation include the following:
(1) Persistent auditory hallucinations occurring in the absence of
any other features.
(2) Delusions with signiﬁcant overlapping mood episodes: This
includes persistent delusions with periods of overlapping
mood episodes that are present for a substantial portion
of the delusional disturbance (such that the criterion stipu-
lating only brief mood disturbance in delusional disorder
is not met).
(3) Attenuated psychosis syndrome: This syndrome is character-
ized by psychotic-like symptoms that are below a thresh-
old for full psychosis (e.g. the symptoms are less severe
and more transient, and insight is relatively maintained).
(4) Delusional symptoms in partners of individual with delusional
disorder: In the context of a relationship, the delusional
material from the dominant partner provides content for
delusional beliefs by an individual whomay not otherwise
entirely meet criteria for delusional disorder.
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psychoses (i.e. major depressive disorder and bipolar
disorder), substance-induced psychoses and with-
drawal states, psychoses caused by a somatic disorder,
and psychotic states associated with neurodegenera-
tive disorders such as dementia, Parkinson’s disease
and Huntington’s disease. Delirium is also sometimes
included as a type of psychosis.
The term ‘psychosis’ therefore lacks a deﬁnition
which provides meaning by specifying its necessary
and sufﬁcient conditions (i.e. an intensional deﬁnition).
Attempts to provide such an intensional deﬁnition in
terms of ‘loss of contact with reality’ or ‘lack of insight’
fail to cover the meaning of psychosis. After all, a loss
of contact with reality cannot be considered sufﬁcient
for psychosis, as this feature may occur in other disor-
ders such as autism, depressive disorder or eating dis-
order; nor is it a necessary feature, since individuals
suffering from hallucinations and negative symptoms
may still be in contact with reality. The same holds
true for lack of insight (David, 1990; Varga et al. 2006).
Instead, ‘psychosis’ owes its meaning to extensional
deﬁnitions which vary somewhat between authors, but
usually consist of lists of psychotic symptoms (such as
those mentioned under the A-criterion above). If we
ask ourselves why symptoms from that disparate
group are called psychotic, we ﬁnd that this serves to
indicate that we consider them severe, and that we sus-
pect them to signal a loss of contact with reality and/or
a lack of insight. Moreover, historically, it suggests that
we consider them to have a neurobiological cause even
though the cause or mechanism may elude us. That is
as close as we can currently get to an intensional
deﬁnition of psychosis.
The question to be answered now, is whether all
patients with one or more psychotic symptoms (such
as persistent, stressful AH) should be considered as
having an underlying psychotic disorder.
Persistent AH in non-psychotic disorders
It is widely recognized that AH can accompany virtu-
ally all psychiatric disorders, including borderline per-
sonality disorder and dissociative identity disorder
(40%), unipolar depression and bipolar disorder
(45%), anxiety disorders (14%), autism (6%), and post-
traumatic stress disorder (15%) (Blom & Sommer, 2010;
Sommer & Kahn, 2014). In addition, AH can be a
symptom of disorders of the nervous system, including
Parkinson’s disease, stroke, and migraine (Vreeburg
et al. 2016), tumors or lesions to the temporal lobe,
brainstem or thalamus (Braun et al. 2003), sleep disor-
ders (Fortuyn et al. 2009), or due to the effects of alco-
hol and drugs. Sensory disturbances due to conditions
which affect the auditory pathways (e.g. hearing loss,
auditory cortex dysfunction, etc.) are also a common
cause.
Hallucinations in these different groups of clinical
disorders can be persistent and distressing, and be
associated with a depressed mood, anxiety, and sui-
cidal behavior (Honig et al. 1998; Okulate & Jones,
2003; Blom & Sommer, 2010; Kingdon et al. 2010;
Preti et al. 2014). Even though such AH can also pre-
sent with signiﬁcant impairments in social, occupa-
tional and other areas of functioning, they are not
always accompanied by problems with reality testing,
lack of insight or disturbed beliefs, and therefore can-
not be considered as part of a psychotic disorder.
Hallucinations in individuals in the general
population
One such example is that of AH reported by indivi-
duals in the general population. In the so-called
‘extended phenotype’ (van Os et al. 2009), prevalence
estimates of hallucinations vary from 4% to 21%
(Beavan et al. 2011). Hallucinations in this group are
often transient and sporadic in nature (Hanssen et al.
2005), although AH can be recurrent and persistent
in a minority (4%) (McGrath et al. 2015). In this latter
group, AH can be highly distressing in approximately
50% of cases (Honig et al. 1998; Daalman et al. 2011;
Woods et al. 2015), and may last for over a year
(Peters et al. 2016). In one study of 13 voice hearers
in the general population, hallucinations had been
ongoing for longer than 4 years in 89% of cases
(Leudar et al. 1997). These types of hallucination pre-
sent mostly without any other psychotic symptoms,
and there is a marked absence of psychopathology
but for schizotypal traits (Sommer et al. 2010).
Explanations for AH which do not involve dopamine
Dopamine has once been hailed as the ‘wind of the
psychotic ﬁre’ (Laruelle & Abi-Dargham, 1999), and
antipsychotic medications with their antagonistic
effects on dopamine receptors are routinely used to
treat psychotic symptoms, whether or not in combin-
ation with psychosocial approaches. Evidence is accu-
mulating, however, that the causes of AH do not
always involve abnormal dopamine functions, raising
questions about the systematic usage of antipsychotic
medications for all symptoms considered as psychotic.
Pharmacological evidence
Dopaminergicoveractivity in thestriatum(Abi-Dargham
et al. 1998) is the primary neuropharmacological
explanation for positive symptoms in schizophrenia dis-
orders. In support, PositronEmission Tomography (PET)
studies using an F-Dopa tracer show that many
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individuals with these disorders have increased pre-
synaptic striatal dopamine production (Howes et al.
2011). Using the same method, a study in individuals
from the general population (e.g. nonpsychotic) with fre-
quent AH failed to show any such increases of striatal
dopamine production (Howes et al. 2013). This perhaps
suggests that individuals who participated in the latter
study may not have been beneﬁted from antipsychotic
treatment in the treatment of their hallucinations. In
support, other PET studies indicate that targeting dopa-
mine (D2) receptors with antipsychotic medication is
only beneﬁcial for individuals with increased striatal
dopamine production, and not for those with normal
production levels (Demjaha et al. 2012; Ćurčić-Blake
et al. 2017).
Consequently, it is perhaps not surprising that recent
evidence is pointing to neurotransmitter systems other
than dopamine in the mediation of AH (Deamer &
Wilkinson, 2015). In regards to the glutamatergic system,
for example, studies show elevated levels of glutamate
and glutamine metabolites in the temporal and frontal
brain regions of individuals diagnosed with schizophre-
nia with frequent and severe AH (Hayward et al. 2009;
Hugdahl et al. 2015;Ćurčić-Blake et al. 2017). In addition,
studies with ketamine show that drugs which alter
glutamatergic neurotransmission are also capable of
producing AH (Corlett et al. 2011). Such a role for the
glutamatergic system cannot be linked directly to the
dopamine hypothesis of psychotic disorders. Despite
attempts to couple both views by considering a role
for aberrant NMDA-R plasticity (Thomas et al. 2014),
the glutamate system appears to form an alternative
mediating pathway for AH, consistent with the hetero-
geneity of conditions in which such hallucinations
present.
To complicate things further, hallucinations in differ-
ent sensory modalities - even when experienced in the
context of the same disorder – may be mediated by dif-
ferent types of neurotransmitter. In the case of visual
hallucinations, for example, 5HT-2a receptors appear
to play a pivotal role given that serotonin agonists
such as LSD and psilocybin can produce vivid halluci-
nations, which can subsequently be blocked with sero-
tonin (5HT-2A) antagonists such as ketanserin and
ritanserin (Vollenweider, 1998). This evidence points
to different neurotransmitter pathways for hallucina-
tions in different sensory modalities, again forcing
the conclusion that the dopamine hypothesis of schizo-
phrenia does not provide an explanation for all types
of hallucination.
Environmental and psychological explanations
Other evidence that dopamine is not always directly
involved in AH stems from studies on environmental
and psychological factors. In vulnerable and older age
groups, social isolation andwithdrawal can be powerful
causes for AH and other types of hallucination through
the reduction of ordinary levels of sensory input. It has
been speculated that the psychological effects of
loneliness and social seclusion may prompt compensa-
tory hypersensitivity of the perceptual network, with
any hallucinations being projected outwards to meet
the person’s communicative needs (Hoffman, 2007).
Psychological trauma is yet another potential cause for
hallucinations. Some people can trace their symptom’s
onset back to traumatic events. This association has
been found inmany individuals diagnosedwith schizo-
phreniawho report abuse in childhood (Read et al. 2005),
and to an even greater extent in individuals with
borderline personality disorder and post-traumatic
stress disorder experiencing AH. In the general commu-
nity, traumatic events also have a substantive power to
trigger hallucinations. For example, up to 80% of the
recently bereaved report hallucinations of their loved
one within the ﬁrst month of the person’s death
(Grimby, 1993). Although predominantly visual in
nature, these hallucinations can also have an auditory
component. In youth, stressors such as bullying and
sexual trauma are strong predictors of AH (Lardinois
et al. 2011).
But even outside the context of trauma, psychological
factors in general appear to play a pivotal role in
prompting hallucinations. Hypervigilance, for example,
and the way situations are appraised, act to shape and
give credence to AH (Campbell & Morrison, 2007),
with anxiety acting to reduce the threshold for accepting
ambiguous signals as real. Everyday examples include
mothers believing their babies to be crying, and physi-
cians on duty hearing the phantom ring of their pagers.
In general, all conditions which are accompanied by
high expectancy for a perceptual signal are a fertile
ground for hallucinations.
Even though it is sometimes possible to treat such
psychosocially-inducedhallucinationswith antipsycho-
tics, psychosocial interventions should be the treatment
of ﬁrst choice. Options could include case-management
approaches, psychoeducation, improving coping
mechanisms, cognitive therapies (Hayward et al. 2009;
Deamer & Wilkinson, 2015), cognitive-behavioral ther-
apy (CBT) (Thomas et al. 2014), trauma-related therapy
(McCarthy-Jones & Longden, 2015; Steel, 2015), voice-
dialoging (Corstens et al. 2012),mindfulness approaches
(Strauss et al. 2015), and integrative treatments (Jenner
et al. 2004).
In all, the above body of evidence converges with
ﬁndings from the literature on schizophrenia, but
also with the notion that there are many pathways
independent of the dopamine system which are cap-
able of eliciting hallucinations.
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Are hallucinations a risk factor for later psychosis?
The question of whether isolated AH constitute a risk
factor for developing a psychotic disorder, and therefore
whether individuals with these experiences should
receive early therapeutic interventions, cannot be
answered conclusively. At this stage, however, the exist-
ing evidence suggests that the risk is low, unless AH are
accompanied by other psychotic symptoms and/or
functional deﬁcits. Longitudinal follow-up studies of
individuals who ﬁrst experienced AH in childhood or
early adolescence conﬁrm this (Poulton et al. 2000).
While the prevalence of hallucinations in children is
relativelyhigh (i.e. 9%), theseexperiences are largely tran-
sient in nature (Jardri et al. 2014). A study of 337 children
aged 7–8 years reporting hallucination-like experiences
demonstrated that these experiences ceased spontan-
eously within 5 years in 76% of cases (Bartels-Velthuis
et al. 2011). Rather than being associated with a later
psychotic disorder, AH in children and adolescents are
more frequently associated with a later depressive dis-
order, anxiety disorder or behavioral problems, even
after adjusting for alcohol and illicit-substance abuse
(Kelleher et al. 2012). Other studies concur, showing
that the odds of AH alone to predict a psychotic disorder
are low, unless they are accompanied by functional deﬁc-
its or beliefs about malevolent intentions of the voices
(Poulton et al. 2000; Daalman et al. 2016).
Other evidence comes from studies showing that the
transition rate of young individuals with subclinical
symptoms to psychosis varies widely. Psychotic symp-
toms that include hallucinations, delusional ideation and
self-disturbances confer a relatively high risk for psychotic
disorders in adulthood (Krabbendam et al. 2004), but less
so when AH occur in isolation (Daalman et al. 2016). A
number of variables appear to inﬂuence the transition to
psychosis, including the persistence of symptoms over
time, the onset of secondary delusions, depression, affect-
ive dysregulation and psychosocial dysfunction (Kaymaz
& van Os, 2010). Conduct disorder, when co-occurring
with AH, also predicts the transition to more severe
forms of psychopathology (Askenazy et al. 2007).
Finally, studies of individuals in the prodromal
phase (and in those with a diagnosis of schizophrenia
spectrum disorder) show that no single symptom can
predict the development of psychotic disorder or
relapse into psychosis. More accurate predictions
depend on features such as other psychotic manifesta-
tions, cognitive dysfunction, depression, and poor
social functioning (Yung et al. 2003).
Conclusions
Altogether, AH and other hallucinations occur at rela-
tively high rates in many different conditions and are
not pathognomonic for any given disorder (including
schizophrenia) (Ford et al. 2014). AH can occur without
other psychotic symptoms and may be caused by a
range of conditions in which dopaminergic transmis-
sion is not compromised. In all cases, an accurate
diagnosis is critically important, as persistent AH as
part of a psychotic disorder may be a good indication
for antipsychotic medication, whereas persistent AH in
the absence of such a disorder are probably not.
Although antipsychotic medication can be very
effective and potentially life-saving in individuals
with psychotic disorders, it is questionable whether it
should be offered to all individuals with AH.
We believe the ambiguous use of the term ‘psych-
osis’ has caused much confusion in the minds of pro-
fessionals and the lay public, and that the distinction
between psychotic symptom and psychotic disorder is
a particularly important one since psychotic symptoms
can occur outside of a psychotic disorder. The habitual
conceptualization of AH as a sure sign of schizophre-
nia spectrum disorder is a particularly good example
of this problem, although a primary diagnosis of
psychotic disorder is not justiﬁed for all individuals
troubled by persistent hallucinations.
The roots of classiﬁcation systems in conventional
medical models require a diagnosis to rest on the pres-
ence and absence of several symptoms to determine
whether the criteria for a speciﬁc syndrome or disorder
may be fulﬁlled. In the traditional view of psychosis
(as a state of distorted reality testing etcetera), the con-
comitant expression of at least one more psychotic
symptom is critical. To that end, the DSM’s
A-criterion for schizophrenia is very useful, since it
demands the presence of at least two psychotic symp-
toms. In the sole presence of persistent hallucinations,
we argue that the diagnostic criteria for Other
Speciﬁed Schizophrenia Spectrum And Other
Psychotic Disorder is not helpful.
Alternative locations for the listing of hallucinations
in textbooks of psychiatry include other syndromes
and disorders where the presence of other symptoms
fulﬁl the criteria for these conditions (e.g. PTSD, bor-
derline personality disorder, etc). Where other symp-
toms or the underlying cause cannot be clearly
established or ascertained, a broader category akin to
the ICD’s R44 (‘symptoms involving general sensa-
tions and perceptions’) may be helpful, perhaps
under a new banner titled ‘Perceptual disorders’.
This new domain could include a class of perceptual
phenomena causing distress and dysfunction, but
without any impaired reality testing (including tin-
nitus, Charles Bonnet Syndrome, phantom limb pain,
pareidolia, and Alice in Wonderland syndrome, to
mention a few examples). This may help to improve
differential diagnosis, and in differentiating between
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individuals who may beneﬁt from antipsychotic medi-
cation and those who may not. Altogether, we should
take note that the presence of persistent AH does not
equate the presence of a psychotic disorder, and
should therefore not uncritically be diagnosed or trea-
ted as such.
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